jueves, 24 de marzo de 2022

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? - The Lancet Respiratory Medicine

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? - The Lancet Respiratory Medicine

No hay comentarios: